Takeyoshi Yamashita
Directeur Technique/Scientifique/R&D chez KYOWA KIRIN CO. LTD.
Postes actifs de Takeyoshi Yamashita
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KYOWA KIRIN CO. LTD. | Directeur/Membre du Conseil | 01/03/2023 | - |
| Directeur Technique/Scientifique/R&D | 01/04/2023 | - | |
| Corporate Officer/Principal | 01/04/2015 | 01/04/2023 | |
| ORCHARD THERAPEUTICS PLC | Directeur/Membre du Conseil | 24/01/2024 | - |
Historique de carrière de Takeyoshi Yamashita
Statistiques
Internationale
| Japon | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KYOWA KIRIN CO. LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Takeyoshi Yamashita
- Expérience